A research article on the effectiveness and safety of the non-peptide glucagon-like peptide- 1 (GLP- 1) receptor agonist Orforlipron than once daily oral therapy for weight reduction in adults with obesity
This precision neurology approach, leveraging the unique insights from circRNA, is critical to facilitating early diagnosis and treatment for Alzheimers. Trontinemab, a disease-modifying drug designed to rapidly clear amyloid plaques from the brain, is moving ahead into Phase III trials
For general wellness, many patients come in once or twice a month
For general skin anti-aging, systemic subcutaneous injection at 1 to 2 mg/day combined with topical application achieves the best tissue-level collagen response
Clinical Diabetes: A Publication of the American Diabetes Association, 41 (3), 467473
To book a free consultation for glutathione IV therapy, Lumecca IPL treatment, chemical peel, and other treatments at our Toronto spa, get in touch with me today.